Taken together, the data suggest that CaMKK2 may be an upstream regulator determining the activity of AMPKα and mediating the alleviating effects of FGF21 on diabetes-induced oxidative stress and endothelial dysfunction. This evidence concerns the gene CAMKK2 and diabetes mellitus.